Safety Assessment Programs for U.S. Regulatory Agencies: A Perspective of Requirements and Compliance

Abstract

Regulatory agencies and components within agencies in the United States have been established at different times but with the same basic charge: to protect the health and welfare of the citizenry by regulating the manufacture and use of chemicals and devices that might constitute a threat to the environment or a health hazard for individuals, groups of individuals, or the population as a whole. The character of each agency differs because of the political climate in which it has evolved, the personalities of the leadership, and the internal philosophies concerning how the agency's charge under the letter of the law should be accomplished in keeping with the congressional intent for establishment of the agency. The current safety assessment program requirements/guidelines and some aspects of their interpretation and application are discussed for the Environmental Protection Agency and for components of the Food and Drug Administration, including the Center for Drug Evaluation and Research, the Center for Biologics Evaluation and Research, and the Center for Veterinary Medicine.

Keywords

Toxicology health environment EPA (Environmental Protection Agency)FDA (Food and Drug Administration)guidelines

References

1. D'Aguanno W (1976). Drug toxicity evaluation–- Preclinical aspects. In: National and International Drug Safety Guidelines (1988), S Alder and G Zbinden (eds). M. T. C. Verlag Zollikon, Zollikon, Switzerland, pp. 167–169.

2. D'Aguanno W (1976). Guidelines for reproduction studies for safety evaluation of drugs for human use. In: National and International Drug Safety Guidelines (1988), S Alder and G. Zbinden (eds). M. T. C. Verlag Zollikon, Zollikon, Switzerland, p. 170.

3. EPA, Office of Pesticide Programs (1984). Hazard evaluation: Human and domestic animals. Pesticide Assessment Guidelines, Subdivision F.

4. EPA, Office of Pesticide Programs (Revised July 1, 1991). Toxicology Data Requirements (158,340) and Wildlife and Aquatic Organisms Data Requirements (158.490). Code of Federal Regulations, Title 40, Part 158, Subpart D.

5. EPA, Office of Toxic Substances (1985). Environmental Effects Testing Guidelines. Code of Federal Regulations, Title 40, Part 797.

6. EPA, Office of Toxic Substances (1985). Health Effects Testing Guidelines. Code of Federal Regulations, Title 40, Part 798.

7. FDA, Bureau of Foods (1982). Toxicologic Principles for the Safety Assessment of Direct Food Additives and Color Additives in Food. Federal Register, Vol. 47; p. 46,141 (October 11, 1982).

8. FDA, Center for Drug Evaluation and Research (February 1987). Guideline for the Format and Content of the Nonclinical/Pharmacology/Toxicology Section of an Application.

9. FDA, Center for Drug Evaluation and Research (February 1987). Guideline for the Format and Content of the Summary for New Drug and Antibiotic Applications.

10.

10. FDA, Center for Drug Evaluation and Research (1985). New Drug and Antibiotic Regulations: Final Rule. Federal Register. Part II, Nonclinical Pharmacology and Toxicology Section (paragraph 314.50(d)(2)), (February 22, 1985).

11.

11. FDA, Center for Drug Evaluation and Research (1987). New Drug, Antibiotic, and Biologic Drug Product Regulations: Final Rule. Federal Register, Part VII, Pharmacology and Toxicology Information (paragraph 312.23 (a)(8)), (March 19, 1987).

12.

12. FDA, Center for Veterinary Medicine (1985). Sponsored Compounds in Food-Producing Animals; Proposed Rule and Notice. (Code of Federal Regulations, Title 21, Parts 70, 500, 514, and 571). Federal Register, Part II, Vol. 50, No. 211 (October 31, 1985).

13.

13. FDA, Center for Veterinary Medicine (1986). General Principles for Evaluating the Safety of Compounds Used in Food Producing Animals.

14.

14. FDA, Center for Veterinary Medicine (1989). Target Animal Safety Guidelines for New Animal Drugs.

15.

15. FDA, Center for Veterinary Medicine (1990). Guideline for Target Animal Safety and Efficacy Review: Category II Supplements, New Drug Applications.

16.

16. FDA, National Center for Drugs and Biologics (Draft, November 7, 1983). Points to consider in the production and testing of new drugs and biologicals produced by recombinant DNA technology. In: National and International Drug Safety Guidelines (1988), S Alderand G. Zbinden (eds). M. T. C. Verlag Zollikon, Zollikon, Switzerland, pp. 183–184.

17.

17. FDA, National Center for Drugs and Biologics (Draft, not dated). Points to consider in the manufacture of monoclonal antibody products for human use. In: National and International Drug Safety Guidelines (1988), S Alder and G. Zbinden (eds). M. T. C. Verlag Zollikon, Zollikon, Switzerland, pp. 184–185.

18.

18. PMA (February 1977). Guidelines for the Assessment of Drug and Medical Device Safety in Animals. In: National and International Drug Safety Guidelines (1988), S Alder and G. Zbinden (eds). M. T. C. Verlag Zollikon, Zollikon, Switzerland, pp. 172–180.

19.

19. Rodricks JV , Starr TB , and Taylor MR (1991). Evaluating the safety of carcinogens in food–-Current practices and emerging developments. Food Drug Cosmetic Law J. 46: 529–530.